NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

NCT02849457

CompletedPhase 2

Sponsor: Martina Bebin

Conditions: Tuberous Sclerosis Complex

Interventions: Early Vigabatrin, Delayed Vigabatrin (Placebo)

Countries: United States

Study design is a Phase IIb prospective multi-center, randomized, placebo-controlled, double-blind clinical trial. The goal will be to enroll 80 infants with Tuberous Sclerosis Complex who are less than 6 months of age prior to the onset of their first seizure

Eligibility overview

Sex: ALL

Age: 1 Day to 6 Months

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

1. less than or equal to 6 months of age
2. No history of seizures or infantile spasms, or evidence of subclinical electrographic seizures on a previous video EEG
3. Meet genetic or clinical diagnostic criteria for TSC, the latter based on current recommendations for diagnostic evaluation, such as physical exam, neuroimaging, echocardiogram

Exclusion Criteria:

1. Is greater than 6 months of age
2. Has not been diagnosed with TSC
3. History of seizures or infantile spasms, or evidence of subclinical electrographic seizures on a previous video EEG
4. Has received any anticonvulsant medication including vigabatrin, other anti-seizure therapeutic agent including cannabidiol
5. Has received an oral mTOR inhibitor such as everolimus or sirolimus
6. Has taken an investigational drug, including but not limited to cannabidiol, as part of a research study 30 days prior to enrollment, or plans on taking an investigational drug at any time during the duration of the study
7. Is currently enrolled, or plans on enrolling at any time during the duration of the study, in an experimental behavioral early intervention study
8. Has a history of being born prematurely (born less than \<30 weeks gestation at the time of delivery)
Locations (13)
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Washington D.C., District of Columbia, United States
  • Boston, Massachusetts, United States
  • Royal Oak, Michigan, United States
  • Saint Paul, Minnesota, United States
  • St Louis, Missouri, United States
  • Durham, North Carolina, United States
  • Cincinnati, Ohio, United States
  • Philadelphia, Pennsylvania, United States
  • Houston, Texas, United States
  • Seattle, Washington, United States